In:
Saudi Journal of Medicine & Medical Sciences, Medknow, Vol. 10, No. 2 ( 2022-05), p. 105-110
Abstract:
The introduction of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has been shown to decrease the risk of malignancy (ROM) in The Bethesda System for Reporting Thyroid Cytopathology. This knowledge may alter the management of patients with thyroid nodules. Objectives: To correlate cytological diagnosis with histological diagnosis for establishing the ROM of all Bethesda system categories after the introduction of NIFTP. Methods: This was a retrospective cohort study. All consecutive fine-needle aspiration cytology (FNAC) specimens collected from January 1, 2013, to December 31, 2017, at King Abdullah Medical City, Jeddah, Saudi Arabia, were assessed, and patients who underwent surgical excision of thyroid nodules were further analyzed. The ROM and overall ROM for each Bethesda category were calculated with and without considering NIFTP as a malignant tumor. Results: Overall, 1066 FNAC specimens were collected, of which 281 had a surgical correlation. Our cases included 18 (6.4%) non-diagnostic (ND), 109 (38.8%) benign, 28 (9.9%) atypia/follicular lesion of undetermined significance (AUS/FLUS), 39 (13.8%) follicular neoplasm or suspicion for follicular neoplasm (FN/SFN), 20 (7.1%) suspicion for malignancy (SM), and 67 (23.8%) malignant (POM) cases. After considering NIFTP diagnosis on resection specimens, the ROM decreased as follows: ND, 38.8% to 27.7% ( P = 0.2388); benign, 21.1% to 11.9% ( P = 0.0343); AUS/FLUS, 50% to 39.2% ( P = 0.2089); FN/SFN, 53.8% to 33.3% ( P = 0.0336); SM, 85% to 75% ( P = 0.2147); POM, 95.5% to 88% ( P = 0.0582). Conclusion: The introduction of NIFTP would significantly decrease the ROM of thyroid FNAC in both benign and FN/SFN categories of the Bethesda system.
Type of Medium:
Online Resource
ISSN:
1658-631X
DOI:
10.4103/sjmms.sjmms_202_21
Language:
English
Publisher:
Medknow
Publication Date:
2022
detail.hit.zdb_id:
2734896-9
